NOVEL DYNAMIN2 MUTATION IN ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Ge, Z. [1 ]
Li, M. [2 ]
Zhao, G. [1 ]
Jin, N. [1 ]
Chen, B. [1 ]
Yu, M. D. [3 ]
Li, J. [2 ]
Dovat, S. [4 ]
Song, C. [4 ]
机构：
[1] Southeast Univ, Sch Med, Zhongda Hosp, Hematol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 1, Hematol, Nanjing, Jiangsu, Peoples R China
[3] Thomas Jefferson Univ, Sydney Kimmel Med Coll, Philadelphia, PA 19107 USA
[4] Penn State Univ, Coll Med, Pediat, Hershey, PA USA
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E872
引用
收藏
页码：356 / 357
页数：2
相关论文
共 50 条
  • [31] TARGETED THERAPY USE IN RARE MUTATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Losole, Taylor
    Raulji, Chittalsinh
    Patel, Sachit
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S146 - S146
  • [32] DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia
    Bond, Jonathan
    Touzart, Aurore
    Lepretre, Stephane
    Graux, Carlos
    Bargetzi, Mario
    Lhermitte, Ludovic
    Hypolite, Guillaume
    Leguay, Thibaut
    Hicheri, Yosr
    Guillerm, Gaelle
    Bilger, Karin
    Lheritier, Veronique
    Hunault, Mathilde
    Huguet, Francoise
    Chalandon, Yves
    Ifrah, Norbert
    Macintyre, Elizabeth
    Dombret, Herve
    Asnafi, Vahid
    Boissel, Nicolas
    HAEMATOLOGICA, 2019, 104 (08) : 1617 - 1625
  • [33] P53 MUTATION IN ACUTE T-CELL LYMPHOBLASTIC-LEUKEMIA IS OF SOMATIC ORIGIN AND IS STABLE DURING ESTABLISHMENT OF T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES
    YEARGIN, J
    CHENG, J
    YU, AL
    GJERSET, R
    BOGART, M
    HAAS, M
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05): : 2111 - 2117
  • [34] CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia
    Naik, Jyoti
    Themeli, Maria
    de Jong-Korlaar, Regina
    Ruiter, Ruud W. J.
    Poddighe, Pino J.
    Yuan, Huipin
    Bruijn, Joost D. d.
    Ossenkoppele, Gert J.
    Zweegman, Sonja
    Smit, Linda
    Mutis, Tuna
    Martens, Anton C. M.
    de Donk, Niels W. C. J. van
    Groen, Richard W. J.
    HAEMATOLOGICA, 2019, 104 (03) : E100 - E103
  • [35] MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia
    Astolfi, Annalisa
    Vendemini, Francesca
    Urbini, Milena
    Melchionda, Fraia
    Masetti, Riccardo
    Franzoni, Monica
    Libri, Virginia
    Serravalle, Salvatore
    Togni, Marco
    Paone, Giuseppina
    Montemurro, Luca
    Bressanin, Daniela
    Chiarini, Francesca
    Martelli, Alberto M.
    Tonelli, Roberto
    Pession, Andrea
    ONCOTARGET, 2014, 5 (01) : 120 - 130
  • [36] Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia
    Lulla, Premal D.
    Mamonkin, Maksim
    Brenner, Malcolm K.
    CANCER JOURNAL, 2019, 25 (03): : 199 - 207
  • [37] The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia
    Gianni, Francesca
    Belver, Laura
    Ferrando, Adolfo
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (03):
  • [38] Atypical immunophenotype of T-cell Acute Lymphoblastic Leukemia
    Purohit, Abhishek
    Aggarwal, Mukul
    Pati, Hara P.
    Saxena, Renu
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2014, 57 (04) : 661 - U150
  • [39] T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    MACKINTOSH, W
    RICHARDS, JDM
    JACOBS, P
    SOUTH AFRICAN MEDICAL JOURNAL, 1985, 67 (12): : 450 - 452
  • [40] Nelarabine (Arranon) for T-cell acute lymphoblastic leukemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1228): : 14 - 15
12345